Rehabilitation and MS

International MS Journal

Volumn 14, Issue 3, 2007, Pages 85-92

  Stevenson, Valerie L ^a   Playford, E D ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Multidisciplinary team; Multiple sclerosis; Rehabilitation

Indexed keywords

METHYLPREDNISOLONE;

CORTICOSTEROID THERAPY; DISABILITY; DISEASE SEVERITY; DRUG MEGADOSE; EVALUATION; HUMAN; INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH; MULTIPLE SCLEROSIS; NURSE; OCCUPATIONAL THERAPIST; PATIENT ASSESSMENT; PHYSIOTHERAPIST; PSYCHOLOGIST; RELAPSE; REVIEW; SOCIAL STATUS; SPEECH THERAPY; TEAM BUILDING; INTERDISCIPLINARY COMMUNICATION; PATIENT CARE; RECURRENT DISEASE;

DISABILITY EVALUATION; HUMANS; INTERDISCIPLINARY COMMUNICATION; MULTIPLE SCLEROSIS; PATIENT CARE TEAM; RECURRENCE;

EID: 38449089069     PISSN: 13528963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Corbin JM. The Corbin and Strauss chronic illness trajectory model: an update. Sch Inq Nurs Pract 1998; 12: 33-41.
2. Corbin JM, Strauss A. A nursing model for chronic illness management based upon the trajectory framework. Sch Inq Nurs Pract 1991; 5: 155-174.
3. NHS Executive. London: Department of Health, 1997. Rehabilitation - A Guide. 〈http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH_4005244〉 Last accessed 24 July 2007.
4. Wade DT, de Jong BA. Recent advances in rehabilitation. BMJ 2000; 320: 1385-1388.
5. World Health Organization (WHO). 2001. International classification of functioning, disability and health. 〈http://www3.who.int/icf/ icftemplate.cfm〉 Last accessed 24 July 2007.
6. Playford ED. Multidisciplinary Rehabilitation. In: Rehabilitation of Multiple Sclerosis (Thompson AJ, ed). Abingdon, UK: Informa Healthcare 2006; pp67-86.
7. Shepherd G, Case management. Health Trends 1990; 22: 59-61.
8. Hill MC, Johnson J. An exploratory study of nurses' perceptions of their role in neurological rehabilitation. Rehabil Nurs 1999; 24: 152-157.
9. Forbes A, While A, Dyson L, Grocott T, Griffiths P. Impact of clinical nurse specialists in multiple sclerosis - synthesis of the evidence. J Adv Nurs 2003; 42: 442-462.
10. MS Trust. Therapists in MS: Delivering the long term solutions, March 2006. Available from 〈http://www.mstrust.org.uk/downloads/therapists_in_ms. pdf〉 Last accessed 24 July 2007.
11. Cunningham C, Horgan F, Keane N, Connolly, Mannion A, O'Neill D. Detection of disability by different members of an interdisciplinary team. Clin Rehab 1996; 10: 247-254.
12. Schut HA, Stam HJ. Goals in rehabilitation teamwork. Disabil Rehabil 1994; 16: 223-226.
13. Rossiter D, Thompson AJ. Introduction of integrated care pathways for patients with multiple sclerosis in an inpatient neurorehabilitation setting. Disabil Rehabil 1995; 17: 443-448.
14. Playford ED, Rossiter D, Werring DJ, Thompson AJ. Integrated care pathways: Evaluating in-patient rehabilitation in stroke. Br J Ther Rehab 1997; 4: 97-102.
15. Kitchiner D, Davidson C, Bundred P. Integrated care pathways: effective tools for continuous evaluation of clinical practice. J Eval Clin Pract 1996; 2: 65-69.
16. Lowe C. Care pathways: have they a place in 'the new National Health Service'? J Nurs Manag 1998; 6: 303-306.
17. Mahoney FI, Barthel DW. Functional Evaluation: the Barthel Index. Maryland State Med J 1965; 14: 61-65.
18. Wade DT, Collin C. The Barthel ADL index: a standard measure of physical disability? Int Disabil Studies 1998; 10: 64-67.
19. Dodds TA, Martin DP, Stolov WC, Deyo RA. A validation of the functional independence measure and its performance among rehabilitation patients. Arch Phys Med Rehabil 1993; 74: 531-536.
20. Freeman JA, Hobart JC, Playford ED, Undy B, Thompson AJ. Evaluating neuro-rehabilitation: lessons from routine data collection. J Neurol Neurosurg Psychiatry 2005; 76: 723-728.
21. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
22. Rudick RA, Cutter G, Reingold S. The multiple sclerosis functional composite: a new clinical outcome measure for multiple sclerosis trials. Mult Scler 2002; 8: 359-365.
23. Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS 29): a new patient-based outcome measure. Brain 2001; 124: 962-973.
24. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12). Neurology 2003; 60: 31-36.
25. Hobart J, Riazi A, Thompson AJ, Styles IM, Ingram W, Vickery PJ et al. Getting the measure of spasticity in MS: The Multiple Sclerosis Society Spasticity Scale (MSSS-88). Brain 2006; 129: 224-234.
26. Hobart J. Rating scales for neurologists. J Neurol Neurosurg Psychiatry 2003; 74 (Suppl 4): iv22-iv26.
27. Leary SM, Thompson AJ. Current management of multiple sclerosis. Int J Clin Pract 2000; 54: 161-169.
28. Multiple Sclerosis: management of multiple sclerosis in primary and secondary care. Clinical Guideline 8. National Institute of Clinical Excellence, London. 2003. Available from 〈http://guidance.nice.org.uk/CG8〉 Last accessed July 24 2007.
29. Chataway J, Porter B, Riazi A, Heaney D, Watt H, Hobart J et al. Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trial. Lancet Neurol 2006; 5: 565-571.
30. Lublin FD, Baier M, Cutter G. Effect of relapses on development of residual deficit in multiple sclerosis. Neurology 2003; 61: 1528-1532.
31. Bethoux F, Miller DM, Kinkel RP. Recovery following acute exacerbations of multiple sclerosis: from impairment to quality of life. Mult Scler 2001; 7: 137-142.
32. Craig J, Young CA, Ennis M, Baker G, Boggild M. A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment. J Neurol Neurosurg Psychiatry 2003; 74: 1225-1230.
33. Liu C, Playford ED, Thompson AJ. Does neurorehabilitation have a role in relapsing-remitting multiple sclerosis? J Neurol 2003; 250: 1214-1218.
34. Stevenson VL. Managing symptoms in multiple sclerosis. In: Rehabilitation of Multiple Sclerosis. (Thompson AJ, ed). Abingdon, UK: Informa Healthcare 2006; pp87-108.
35. Kesselring J, Beer S. Symptomatic therapy and neurorehabilitation in multiple sclerosis. Lancet Neurol 2005; 74: 643-652.
36. Freeman JA, Langdon DW, Hobart JC, Thompson AJ. The impact of inpatient rehabilitation on progressive multiple sclerosis. Ann Neurol 1997; 42: 236-244.
37. Freeman JA, Langdon DW, Hobart JC, Thompson AJ. Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community? Neurology 1999; 52: 50-56.
38. Solari A, Filippini G, Gasco P, Colla L, Salmaggi A, La Mantia L et al. Physical rehabilitation has a positive effect on disability in multiple sclerosis patients. Neurology 1999; 52: 57-62.
39. Patti F, Ciancio MR, Reggio E, Lopes R, Palermo F, Cacopardo M et al. The impact of outpatient rehabilitation on quality of life in multiple sclerosis. J Neurol 2002; 249: 1027-1033.
40. Patti F, Ciancio MR, Cacopardo M, Reggio E, Fiorilla T, Palermo F et al. Effects of a short outpatient rehabilitation treatment on disability of multiple sclerosis patients - a randomised controlled trial. J Neurol. 2003; 250: 861-866.
41. Wollin JA, Yates PM, Kristjanson U. Supportive and palliative care needs identified by multiple sclerosis patients and their families. Int J Palliat Nurs 2006; 12: 20-26.
42. Supportive and palliative care: the Manual. NICE, March 2004. Available from 〈http://www.nice.org.uk/110005〉 Last accessed July 24 2007.